Simplex Trading’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-2,735
| Closed | -$110K | – | 9231 |
|
|
2026
Q1 | $110K | Sell |
2,735
-24,452
| -90% | -$527K | ﹤0.01% | 4966 |
|
|
2025
Q4 | $683K | Sell |
27,187
-26,714
| -50% | -$627K | ﹤0.01% | 2995 |
|
|
2025
Q3 | $1.22M | Sell |
53,901
-2,033
| -4% | -$47.4K | ﹤0.01% | 2843 |
|
|
2025
Q2 | $968K | Buy |
+55,934
| New | +$1.04M | ﹤0.01% | 2812 |
|
|
2024
Q4 | – | Sell |
-73,982
| Closed | -$2.22M | – | 8439 |
|
|
2024
Q3 | $2.13M | Buy |
73,982
+3,910
| +6% | +$145K | ﹤0.01% | 2218 |
|
|
2024
Q2 | $2.69M | Buy |
+70,072
| New | +$3.17M | ﹤0.01% | 1942 |
|
|
2024
Q1 | – | Sell |
-44,954
| Closed | -$2.87M | – | 8783 |
|
|
2023
Q4 | $2.69M | Sell |
44,954
-31,911
| -42% | -$1.62M | ﹤0.01% | 2110 |
|
|
2023
Q3 | $2.92M | Buy |
76,865
+854
| +1% | +$37.5K | ﹤0.01% | 1764 |
|
|
2023
Q2 | $6.92M | Buy |
76,011
+72,588
| +2,121% | +$6.26M | 0.01% | 1107 |
|
|
2023
Q1 | $225K | Buy |
+3,423
| New | +$198K | ﹤0.01% | 4183 |
|
|
2022
Q4 | – | Sell |
-29,627
| Closed | -$1.57M | – | 9128 |
|
|
2022
Q3 | $2.02M | Buy |
29,627
+19,463
| +191% | +$1.15M | ﹤0.01% | 1944 |
|
|
2022
Q2 | $459K | Buy |
10,164
+7,197
| +243% | +$328K | ﹤0.01% | 3533 |
|
|
2022
Q1 | $150K | Buy |
+2,967
| New | +$131K | ﹤0.01% | 5580 |
|
|
2021
Q1 | – | Sell |
-1,456
| Closed | -$68.9K | – | 8736 |
|
|
2020
Q4 | $0 | Sell |
1,456
-2,808
| -66% | -$119K | ﹤0.01% | 8277 |
|
|
2020
Q3 | $0 | Sell |
4,264
-261
| -6% | -$7.8K | ﹤0.01% | 7732 |
|
|
2020
Q2 | $147K | Sell |
4,525
-1,429
| -24% | -$45.9K | ﹤0.01% | 4355 |
|
|
2020
Q1 | $159K | Buy |
+5,954
| New | +$211K | ﹤0.01% | 3852 |
|
|
2019
Q4 | – | Sell |
-2,489
| Closed | -$68.9K | – | 7240 |
|
|
2019
Q3 | $59K | Buy |
2,489
+2,414
| +3,219% | +$66.4K | ﹤0.01% | 4842 |
|
|
2019
Q2 | $1K | Buy |
+75
| New | +$1.53K | ﹤0.01% | 6840 |
|
Other funds holding APLS
Simplex Trading's APLS Position: Q2 2026 in Review
Simplex Trading sold out of Apellis Pharmaceuticals (APLS) in Q2 2026, closing a stake of 2,735 shares — an estimated $110K sold.
Simplex Trading first reported a position in APLS in Q2 2019 and held it in 19 quarters. The position peaked at $6.92M in Q2 2023. 1 fund tracked by Wall St. Rank holds APLS as of Q2 2026.
- Simplex Trading reported no remaining Apellis Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
- Simplex Trading sold 2,735 Apellis Pharmaceuticals shares in Q2 2026, an estimated $110K.
- Simplex Trading first reported a position in Apellis Pharmaceuticals in Q2 2019 and held it in 19 quarters.
- Simplex Trading's Apellis Pharmaceuticals position peaked at $6.92M in Q2 2023.
- 1 fund tracked by Wall St. Rank held Apellis Pharmaceuticals as of Q2 2026.
Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.